The Five Types of Cancer with the Most Expensive Medications

Researchers have come a long way in developing effective treatments for a variety of different kinds of cancer. Unfortunately, the companies who hold the patents on may of these potentially life saving or life extending drugs have placed a high price tag on their use. This makes it difficult and in some cases impossible for the patients who need them the most to gain access. Here re the five types of cancer with the most expensive medications.

5. Prostate cancer

The drug Xofigo is the fifth most expensive cancer treatment drug. It is used in the treatment of late stage prostate cancer which has metastasized into the bones but has not yet entered other organs in the body. This is a very specific group of patients with cancer diagnoses. The total monthly cost of using this drug per patient is a whopping $12,657. The drug was approved for use in late stage prostate cancer patients in May of 2013 and it is used in patients who did not achieve results with other types of treatments. Clinical trials have shown positive results for effectiveness in concentrating the effects of radiation directly into tumors in the bone, extending life expectancy from 11.2 months to 14 months on average.

4. Stomach cancer and non-small cell lung cancer

A drug called Cyramza is used in the treatment of stomach cancer and non small cell lung cancer. It was approved by the FDA for the treatment of these conditions in April of 2013. The monthly cost per patient for Cyramza is $13,256. This drug works by inhibiting the blood supply that is required for tumor growth. It’s a drug that is used when other treatments have failed to slow the progression of cancer. It is manufactured by Eli Lilly and it has been found to be effective in treating small cell lung cancer along with docetaxel, a type of chemotherapy. The sales of this drug are steadily growing despite its high cost to approximately $134 million with expectations that these figures will rise dramatically within the year.

3. Late stage non-small cell lung cancer

The third most expensive drug used in cancer treatment is Zykadia. The monthly cost to administer this drug to patients is $13,672. It was approved by teh FDA to treat non small cell lung cancer in the late stage four months ahead of its original schedule. It is most commonly used in the treatment of patients who have had a return of the disease after they’ve been treated with crizotinib. This is a rare population among cancer sufferers as only between two to seven percent of patients are ALK Positive. This drug has shown effectiveness in clinical trials with half of the patients seeing their tumors shrink. The total sales for the drug so far have only been $31 million.

2. Differentiated thyroid cancer

This type of thyroid cancer, also known as DTC is treated with the second most expensive oncology treatment drug known as Lenvima. Lenvima costs $17,000 per month per patient before discounts. It was approved by the FDA for use n 2011. It is used for patients whose cancer has still progressed with other types of treatments. Lenvima works by blocking proteins that are necessary for cancer cells to grow and replicate. Results show that patients who take this drug saw a period of 18.3 months without disease progression verses the 3.6 months for those receiving a placebo.

1. Acute lymphoblastic leukemia

The most expensive cancer treatment drug in the world is Blincyto. It costs a staggering $64,260 per month per patient for use. This drug was just recently approved for use in the treatment of this type of cancer in December of 2018. It is used to boost patient immune system and to seek out and destroy leukemia cells. There are not yet any figures associated with the current total sales of this drug because it is so new on the market but the figures are expected to be high because of its effectiveness in clinical trials.  Blincyto is the most expensive cancer treatment drug that has ever been developed.


Add Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

How Chad Hugo Achieved a Net Worth of $55 Million
Donna Dubinsky
10 Things You Didn’t Know about Donna Dubinsky
How Jim Thome Shifted from MLB Slugger to Business
Mike Petters Huntington Ingalls
10 Things You Didn’t Know about Huntington Ingalls CEO Mike Petters
Chase Slate
20 Benefits of Having a Chase Slate Card
chase sapphire reserve card
How to Get The Most out of Chase Sapphire Reserve Concierge
interest Rates
Understanding the Interest Rates Phenomenon
Why Microsoft (MSFT) is a Safe Dividend Stock for the Next 20 Years
Productivity 101: Why you Should Consider a Time Tracking Tool
Biosphere 2
Closed Ecological Systems: Can They Save the Future?
brain computer interface
How Close is Brain-Computer Interface To Being a Reality?
agricultural robots
What Are Agricultural Robots and How Will They Change the Future?
10 Reasons to Stay at the Ritz-Carlton Cancun
rainbow flag
LGBTQ Travel: Stay Safe and Travel Smart
10 Reasons to Visit The Hispanic Society of America Museum & Library in New York
10 Reasons to Stay at the Ritz Carlton NYC, Central Park
1961 Ferrari 250 GT LWB California Spider
A Closer Look at the $18.5 Million 1961 Ferrari 250 GT LWB California Spider
1954 Ferrari 375-Plus
A Closer Look at the $18.3 Million 1954 Ferrari 375-Plus
1964 Ferrari 250 LM Rear
Is the 1964 Ferrari 250 LM Really Worth $18.26 Million?
1966 Shelby GT350
The 20 Greatest Muscle Cars of All-Time
A Closer Look at the $3.9 Million Patek Philippe 5004T
A Closer Look at the $3.6 Patek Philippe 1928 Single Button Chronograph
Patek Philippe Pink Gold Pocket Watch 1894
A Closer Look at the $2.29 Million Patek Philippe Pink Gold Pocket Watch 1894
Patek Philippe Perpetual Calendar Chronograph Wristwatch in Pink Gold
A Closer Look at the $2.28 Million Patek Philippe Perpetual Calendar Chronograph Wristwatch in Pink Gold